• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的钠减少干预措施经济评估的系统评价。

A systematic review of economic evaluations of population-based sodium reduction interventions.

作者信息

Hope Silvia F, Webster Jacqui, Trieu Kathy, Pillay Arti, Ieremia Merina, Bell Colin, Snowdon Wendy, Neal Bruce, Moodie Marj

机构信息

Deakin Health Economics, Centre for Population Health Research, Faculty of Health, Deakin University, Burwood, Victoria, Australia.

The George Institute for Global Health, Sydney, Australia.

出版信息

PLoS One. 2017 Mar 29;12(3):e0173600. doi: 10.1371/journal.pone.0173600. eCollection 2017.

DOI:10.1371/journal.pone.0173600
PMID:28355231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5371286/
Abstract

OBJECTIVE

To summarise evidence describing the cost-effectiveness of population-based interventions targeting sodium reduction.

METHODS

A systematic search of published and grey literature databases and websites was conducted using specified key words. Characteristics of identified economic evaluations were recorded, and included studies were appraised for reporting quality using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist.

RESULTS

Twenty studies met the study inclusion criteria and received a full paper review. Fourteen studies were identified as full economic evaluations in that they included both costs and benefits associated with an intervention measured against a comparator. Most studies were modelling exercises based on scenarios for achieving salt reduction and assumed effects on health outcomes. All 14 studies concluded that their specified intervention(s) targeting reductions in population sodium consumption were cost-effective, and in the majority of cases, were cost saving. Just over half the studies (8/14) were assessed as being of 'excellent' reporting quality, five studies fell into the 'very good' quality category and one into the 'good' category. All of the identified evaluations were based on modelling, whereby inputs for all the key parameters including the effect size were either drawn from published datasets, existing literature or based on expert advice.

CONCLUSION

Despite a clear increase in evaluations of salt reduction programs in recent years, this review identified relatively few economic evaluations of population salt reduction interventions. None of the studies were based on actual implementation of intervention(s) and the associated collection of new empirical data. The studies universally showed that population-based salt reduction strategies are likely to be cost effective or cost saving. However, given the reliance on modelling, there is a need for the effectiveness of new interventions to be evaluated in the field using strong study designs and parallel economic evaluations.

摘要

目的

总结描述以减少钠摄入为目标的人群干预措施成本效益的证据。

方法

使用特定关键词对已发表文献数据库、灰色文献数据库及网站进行系统检索。记录已识别的经济评估的特征,并使用《卫生经济评估报告标准合并清单》(CHEERS清单)对纳入研究的报告质量进行评估。

结果

20项研究符合研究纳入标准并接受全文审查。14项研究被确定为完整的经济评估,因为它们包括与对照措施相比的干预措施相关的成本和效益。大多数研究是基于实现减盐目标的情景进行的建模练习,并假定对健康结果有影响。所有14项研究均得出结论,其针对人群钠摄入量减少的特定干预措施具有成本效益,且在大多数情况下可节省成本。略超过一半的研究(8/14)被评估为报告质量“优秀”,5项研究属于“非常好”质量类别,1项属于“良好”类别。所有已识别的评估均基于建模,其中所有关键参数(包括效应量)的输入数据均来自已发表的数据集、现有文献或基于专家建议。

结论

尽管近年来盐减少计划的评估明显增加,但本综述发现针对人群盐减少干预措施的经济评估相对较少。没有一项研究基于干预措施的实际实施及相关新实证数据的收集。这些研究普遍表明,基于人群的盐减少策略可能具有成本效益或可节省成本。然而,鉴于对建模的依赖,需要使用强有力的研究设计和并行经济评估在实地评估新干预措施的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c4a/5371286/e038b46504a6/pone.0173600.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c4a/5371286/e038b46504a6/pone.0173600.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c4a/5371286/e038b46504a6/pone.0173600.g001.jpg

相似文献

1
A systematic review of economic evaluations of population-based sodium reduction interventions.基于人群的钠减少干预措施经济评估的系统评价。
PLoS One. 2017 Mar 29;12(3):e0173600. doi: 10.1371/journal.pone.0173600. eCollection 2017.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.成人癫痫新药的临床疗效、耐受性及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. doi: 10.3310/hta9150.

引用本文的文献

1
Stakeholder perspectives on scaling up potassium-enriched salt to reduce cardiovascular disease in Australia: a qualitative study.利益相关者对在澳大利亚扩大富钾盐使用以减少心血管疾病的看法:一项定性研究。
BMC Public Health. 2025 Jul 22;25(1):2525. doi: 10.1186/s12889-025-23717-w.
2
Health Economic Evaluations in Intensive Care: An Updated Systematic Review.重症监护中的卫生经济评估:一项更新的系统评价。
Crit Care Explor. 2025 Jul 16;7(7):e1288. doi: 10.1097/CCE.0000000000001288. eCollection 2025 Jul 1.
3
The potential health impact and healthcare cost savings of different sodium reduction strategies in Canada.

本文引用的文献

1
Salt Intakes, Knowledge, and Behavior in Samoa: Monitoring Salt-Consumption Patterns Through the World Health Organization's Surveillance of Noncommunicable Disease Risk Factors (STEPS).萨摩亚的盐摄入量、知识与行为:通过世界卫生组织非传染性疾病风险因素监测(STEPS)来监测盐消费模式
J Clin Hypertens (Greenwich). 2016 Sep;18(9):884-91. doi: 10.1111/jch.12778. Epub 2016 Feb 3.
2
Salt Reduction Initiatives around the World - A Systematic Review of Progress towards the Global Target.全球减盐倡议——对实现全球目标进展的系统评价
PLoS One. 2015 Jul 22;10(7):e0130247. doi: 10.1371/journal.pone.0130247. eCollection 2015.
3
加拿大不同钠减排策略对健康的潜在影响及医疗成本节约情况。
BMC Public Health. 2025 Jul 3;25(1):2379. doi: 10.1186/s12889-025-22941-8.
4
Evaluation of Reporting Quality of Systematic Reviews on Health Economic Evaluation Studies Based on the CHEERS Statement: An Overview of Reviews.基于CHEERS声明对卫生经济评估研究系统评价报告质量的评估:综述概述
Iran J Public Health. 2024 Oct;53(10):2214-2225. doi: 10.18502/ijph.v53i10.16699.
5
Monitoring sodium content in processed and ultraprocessed foods in Argentina 2022: compliance with National Legislation and Regional Targets.2022年阿根廷加工食品和超加工食品中钠含量监测:是否符合国家立法和区域目标。
Public Health Nutr. 2024 Oct 2;27(1):e193. doi: 10.1017/S1368980024001423.
6
Cost-effectiveness of non-communicable disease prevention in Southeast Asia: a scoping review.东南亚非传染性疾病预防的成本效益:范围综述。
Front Public Health. 2023 Nov 9;11:1206213. doi: 10.3389/fpubh.2023.1206213. eCollection 2023.
7
Economic effects of dietary salt reduction policies for cardiovascular disease prevention in Japan: a simulation study of hypothetical scenarios.日本预防心血管疾病的膳食减盐政策的经济影响:假设情景的模拟研究
Front Nutr. 2023 Nov 9;10:1227303. doi: 10.3389/fnut.2023.1227303. eCollection 2023.
8
Changes in the Sodium Content in Branded Foods in the Slovenian Food Supply (2011-2020).品牌食品中钠含量在斯洛文尼亚食品供应中的变化(2011-2020 年)。
Nutrients. 2023 Oct 9;15(19):4304. doi: 10.3390/nu15194304.
9
Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia.澳大利亚维多利亚州成年人 statewide减盐计划的结果。
Eur J Nutr. 2023 Oct;62(7):3055-3067. doi: 10.1007/s00394-023-03210-z. Epub 2023 Jul 26.
10
Modelling the impact of sodium intake on cardiovascular disease mortality in Mexico.建立模型以评估墨西哥钠摄入量对心血管疾病死亡率的影响。
BMC Public Health. 2023 May 26;23(1):983. doi: 10.1186/s12889-023-15827-0.
Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis.
细胞周期进展评分在前列腺癌患者中的预后价值:系统评价和荟萃分析。
Eur Urol. 2016 Jan;69(1):107-15. doi: 10.1016/j.eururo.2014.11.038. Epub 2014 Dec 4.
4
An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.减少英格兰盐摄入量以降低冠心病的经济评估:政策建模研究。
Value Health. 2014 Jul;17(5):517-24. doi: 10.1016/j.jval.2014.03.1722. Epub 2014 Jun 2.
5
Global sodium consumption and death from cardiovascular causes.全球钠摄入量与心血管原因导致的死亡。
N Engl J Med. 2014 Aug 14;371(7):624-34. doi: 10.1056/NEJMoa1304127.
6
Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010-2020.2010 - 2020年叙利亚降低冠心病的减盐政策成本效益分析
Int J Public Health. 2015 Jan;60 Suppl 1:S23-30. doi: 10.1007/s00038-014-0577-3. Epub 2014 Jun 28.
7
Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality.2003年至2011年英格兰的减盐情况:其与血压、中风及缺血性心脏病死亡率的关系。
BMJ Open. 2014 Apr 14;4(4):e004549. doi: 10.1136/bmjopen-2013-004549.
8
Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru.在人群中推广使用盐替代品来降低血压:秘鲁的一项集群随机化阶梯式楔形试验。
Trials. 2014 Mar 25;15:93. doi: 10.1186/1745-6215-15-93.
9
A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries.减少食盐政策以降低四个东地中海国家冠心病发病率的成本效益分析。
PLoS One. 2014 Jan 7;9(1):e84445. doi: 10.1371/journal.pone.0084445. eCollection 2014.
10
Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide.1990 年和 2010 年全球、区域和国家钠摄入量:对全球 24 小时尿钠排泄和膳食调查的系统分析。
BMJ Open. 2013 Dec 23;3(12):e003733. doi: 10.1136/bmjopen-2013-003733.